"FDA gives limited OK to Sanofi drug" by Bloomberg News | March 17, 2009
WASHINGTON - Sanofi-Aventis SA's experimental Multaq pill for irregular heartbeat was recommended for limited approval by US regulators yesterday after years of delays.
Multaq prevents recurring symptoms and hospitalizations, although studies are "not convincing" it reduces deaths, as Sanofi had requested, the Food and Drug Administration said in a report on its website. An advisory panel will consider the findings when it votes this week whether the medicine should be sold in the United States.
New products may help the Paris-based company keep pace with its rivals and withstand new competition to its top-selling blood thinners, Lovenox and Plavix. Chief executive Chris Viehbacher says he is more focused on innovative science than joining in the large-scale mergers transforming the global drug industry.
James Knight, an analyst at Collins Stewart in London, in a March 9 note to clients, said he estimated peak annual sales for the drug of $1.4 billion.
--more--"
That ($$$$$$$$)is what it is ALL ABOUT, Americans! NOT your HEALTH!
FDA Protects Big Pharma While Telling Americans "F*** You!"
FDA Doesn't Care About Cancer
FDA Approval to Immunize Drug Companies From Lawsuits
